Rosuvastatin is a recently approved statin and used widely across the globe for primary and
secondary prevention of atherosclerotic cardiovascular heart disease. It has the highest lipid …

Statins as lipid lowering drugs, are safe and effective in reducing cardiovascular disease
risk, but rarely produce myopathy like myalgia, myositis or rhabdomyolysis. We report the …

Statins are the primary class of medication used to lower serum cholesterol concentration for
both primary and secondary prevention of cardiovascular disease. Muscle pain is a frequent …

Background Rhabdomyolysis is a rare but serious complication of lipid-lowering therapy.
Statin and fibrate combination increases the risk of rhabdomyolysis possibly by …

Statins are safe, well tolerated, efficient and time tested drugs for the management of
hypercholesterolemia, and thus play a cardinal role in the management of patients with …

Rhabdomyolysis (RML) is a rare and severe adverse effect of simvastatin (SIM). Several risk
factors have been described which play a role in its pathogenesis, namely age> 65 …

We report a case of rosuvastatin induced rhabdomyolysis in a low risk patient, who
presented with five-day history of generalized muscle pain, weakness and easy fatigability …

Background Rhabdomyolysis is a widely recognized yet rare complication in statin use.
Rhabdomyolysis might be triggered by the prescription of high doses of statins or by statin …

Introduction Rhabdomyolysis associated with the use of pravastatin has been demonstrated
to be a rare but potentially life-threatening adverse effect of statins. Here, we report a rare …

Statins are group of medicines that lower the level of low-density lipoprotein (LDL)
cholesterol. They may exert toxic effects on skeletal muscle ranging from simple muscle pain …